Skip to search formSkip to main contentSkip to account menu

Fezakinumab

Known as: ILV-094, Immunoglobulin G1, Anti-(Human Interleukin 22) (Human Monoclonal Heavy Chain), Disulfide with Human Monoclonal Lambda-Chain, Dimer, Immunoglobulin G1, Anti-(Human/Macaca irus/Rattus/Mus musculus Interleukin 22) (Human Monoclonal Heavy Chain), Disulfide with Human Monoclonal Lambda-Chain, Dimer 
A human monoclonal antibody directed against interleukin-22 (IL-22) with anti-inflammatory activity. Fezakinumab binds to IL-22 and prevents the… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
Severe atopic dermatitis, which affects both adults and children, is a debilitating disorder with a significant decline of… 
2017
2017
Viruses are /the most common factors of pneumonia. The importance of quick diagnosis of viruses is gradually increasing. In this… 
Review
2016
Review
2016
in Wild Life, Braverman explores concepts of in situ and ex situ conservation and the apparent dichotomy between them. Braverman… 
1962
1962
The serum proteins of seven primates are studied by immunoelectrophoresis using heterologons immune serums anti‐Man, anti…